prodromal


Also found in: Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.

pro·drome

 (prō′drōm′)
n.
An early symptom indicating the onset of an attack or a disease.

[French, from Latin prodromus, precursor, from Greek prodromos, precursor : pro-, forward; see pro-2 + dromos, running.]

pro·dro′mal (-drō′məl), pro·drom′ic (-drŏm′ĭk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.prodromal - symptomatic of the onset of an attack or a disease
Translations
prodromal

pro·dro·mal

a. prodrómico-a, rel. a la fase inicial de una enfermedad.
Mentioned in ?
References in periodicals archive ?
William Blair analyst Matt Phipps believes increasing enrollment of Biogen's Phase III trials of aducanumab in prodromal Alzheimer's disease to ensure appropriate powering and confidence interval error margin, which caused yesterday's share selloff, is "prudent and not unusual.
Merck, known as MSD outside the United States and Canada, today announced that it will be stopping protocol 019, also known as the APECS study, a Phase 3 study evaluating verubecestat (MK-8931), an investigational small molecule inhibitor of the beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), in people with prodromal Alzheimers disease (AD).
The team analysed data from 39 studies of prodromal symptoms and risk factors for later development of BD.
This is the stage between normal and mutated cells and is called the pre-dormal and prodromal stages.
Study 201 is a placebo-controlled, double-blind, parallel-group, randomized study in patients with prodromal or mild Alzheimer's disease and with positive biomarkers for brain amyloid pathology.
Exactly 50% of patients had depression preceding their Parkinson's disease diagnosis, while 43% of patients had prodromal anxiety.
Maximum communicability occurs from onset of prodromal phase through the first 3-4 days of rash, he added.
This new trial CREAD2 will recruit 750 patients with prodromal or mild Alzheimer's disease.
These improvements include the loss of their prodromal reactions, being able to gradually expose their skin to light sources and participating in daily activities, something that had been impossible prior to treatment.
The new CREAD2 trial was set to recruit 750 patients with prodromal or mild Alzheimer's disease.
From prodromal phase to the development of psychosis is characterized by "ultrahigh risk symptoms" which is characterized by attenuated positive psychotic symptoms or Brief Limited Intermittent Psychotic Symptoms or Trait and State Risk factors.
As such, treatment is 4 times more effective when started in the prodromal (80%), rather than fulminant (20%), stage of illness (Table 2).